ScienceTechyNews: Tumor cells' drug addiction may be their downfall

Work by researchers at the Babraham Institute in partnership with the global biopharmaceutical company AstraZeneca shows how cancer cells' acquired resistance to anti-cancer drugs proves fatal once the treatment compound is withdrawn.

by